Discover how a newly developed platform technology from The University of North Carolina at Chapel Hill can enhance RNAi potency.

Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...

An international team of scientists has designed a new type of therapy to target the mutant toxic RNA that causes myotonic ...

Fred Hutch researchers invent a CRISPR screening method to understand RNA-binding proteins often mutated in cancer and other diseases In biology’s standard tale of two acids — deoxyribonucleic (DNA) ...

RNA sequencing (RNA-seq) is a powerful tool in diagnosing Mendelian disorders, but the optimized sequencing depth for this technology has not yet been determined. In a new study published in the ...

Increasing paternal age has been linked to elevated health risks for the next generation, including higher risks of obesity ...

Mounting evidence from research on nematodes to mice indicate that a father's environment, such as what he eats or if he is exposed to stress or toxicants, can lead to metabolic and behavioral ...

Bone is a common site for metastasis of solid cancers, but histological and molecular features of bone metastases are not well understood. In a new study published in Cell Genomics, researchers at ...

Eclipsebio Acquires Terrain Bio to Expand Its End-to-End AI Platform for the Design, Manufacturing, and Validation of RNA Therapeutics ...

mRNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there. When you purchase through links on our site, we may earn an affiliate ...